In a recent report, analyst Ben Andrew wrote that the next generation of diabetes management devices should drive patient adoption and use, and he expects revenue to start reflecting the increased adoption and use in 2013. He believes that companies offering insulin pumps and continuous glucose monitoring (CGM) devices represent the future of diabetes care and offer some of the most attractive growth potential in the medical device space.
For more information, please contact your William Blair & Company representative.